A prognostic model integrating clinical information and gene expression signatures in phase III neoadjuvant trial CALGB 40601(Alliance).
- Citation:
- Ann Oncol vol 29 (suppl_7) abstr SPS-3
- Meeting Instance:
- JSMO 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- Yes
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2809
- Pharmas:
- Grants:
- U10CA180821, U24CA196171
- Corr. Author:
- Authors:
- Maki Tanioka Joel S Parker Lynn N Henry Sara Tolaney Chau Dang Ian E Krop Lyndsay Harris David Hillman Mei Polley Donald A Berry Eric P Winer Lisa A Carey Charles M Perou
- Networks:
- LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NY016
- Study
- CALGB-40601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: